German group’s drugs chief warns EU and UK are dissuading investment as company prioritises US and China
Bayer shifts pharma focus away from ‘innovation unfriendly’ Europe
Recent Posts
- Netflix profits jump 24% as viewers flock to streaming shows and sports
- Trump says US will ‘100%’ strike trade deal with EU
- Could Trump fire the Federal Reserve chair?
- US and Ukraine sign memorandum of intent on minerals deal
- Harvard defies Trump administration’s demand for international student data
